These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 32800663)
21. BCLAF1-induced HIF-1α accumulation under normoxia enhances PD-L1 treatment resistances via BCLAF1-CUL3 complex. Yao B; Lu Y; Li Y; Bai Y; Wei X; Yang Y; Yao D Cancer Immunol Immunother; 2023 Dec; 72(12):4279-4292. PubMed ID: 37906282 [TBL] [Abstract][Full Text] [Related]
22. Shuyu pills inhibit immune escape and enhance chemosensitization in hepatocellular carcinoma. Deng Z; Teng YJ; Zhou Q; Ouyang ZG; Hu YX; Long HP; Hu MJ; Mei S; Lin FX; Dai XJ; Zhang BY; Feng T; Tian XF World J Gastrointest Oncol; 2021 Nov; 13(11):1725-1740. PubMed ID: 34853646 [TBL] [Abstract][Full Text] [Related]
23. IL-1β-Induced Elevation of Solute Carrier Family 7 Member 11 Promotes Hepatocellular Carcinoma Metastasis Through Up-regulating Programmed Death Ligand 1 and Colony-Stimulating Factor 1. He Q; Liu M; Huang W; Chen X; Zhang B; Zhang T; Wang Y; Liu D; Xie M; Ji X; Sun M; Tian D; Xia L Hepatology; 2021 Dec; 74(6):3174-3193. PubMed ID: 34288020 [TBL] [Abstract][Full Text] [Related]
24. [Expressions of hepatitis B virus x protein and hypoxia-inducible factor-1alpha in hepatocellular carcinoma and their possible relationships]. Liu KG; Xie HH; Liu J Zhonghua Gan Zang Bing Za Zhi; 2007 Feb; 15(2):122-6. PubMed ID: 17362638 [TBL] [Abstract][Full Text] [Related]
25. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment. Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718 [TBL] [Abstract][Full Text] [Related]
26. Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer. Wu Q; Zhou W; Yin S; Zhou Y; Chen T; Qian J; Su R; Hong L; Lu H; Zhang F; Xie H; Zhou L; Zheng S Hepatology; 2019 Jul; 70(1):198-214. PubMed ID: 30810243 [TBL] [Abstract][Full Text] [Related]
27. Correlation of hypoxia-inducible factor 1alpha with angiogenesis in liver tumors after transcatheter arterial embolization in an animal model. Liang B; Zheng CS; Feng GS; Wu HP; Wang Y; Zhao H; Qian J; Liang HM Cardiovasc Intervent Radiol; 2010 Aug; 33(4):806-12. PubMed ID: 19937023 [TBL] [Abstract][Full Text] [Related]
28. HUVECs affect HuT-78 cell apoptosis and cytokine production via the HIF-1α-PD-L1/PD-1 pathway under hypoxia. Qiang L; Hong L; Jian X; Zhanlin Z Int Immunopharmacol; 2023 May; 118():110010. PubMed ID: 36924563 [TBL] [Abstract][Full Text] [Related]
29. A Combination of UTMD-Mediated HIF-1 Liao Y; Luo H; He Z; Kuang Y; Chen P; Zhang X; Chen J; Wen Q; Xie Y; Ding S Biomed Res Int; 2019; 2019():1937460. PubMed ID: 30911540 [TBL] [Abstract][Full Text] [Related]
30. Immunorthodontics: PD-L1, a Novel Immunomodulator in Cementoblasts, Is Regulated by HIF-1α under Hypoxia. Yong J; Gröger S; von Bremen J; Meyle J; Ruf S Cells; 2022 Jul; 11(15):. PubMed ID: 35954195 [TBL] [Abstract][Full Text] [Related]
31. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells. Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303 [TBL] [Abstract][Full Text] [Related]
32. Rapamycin Combi with TAE on the Growth, Metastasis, and Prognosis of Hepatocellular Carcinoma in Rat Models. Lei HW; Cai J; Li CM; Yang F; Shi WQ; Shi WQ; Wang LP; Feng YY Ann Hepatol; 2018 July - August ,; 17(4):645-654. PubMed ID: 29893708 [TBL] [Abstract][Full Text] [Related]
33. EZH2 regulates PD-L1 expression via HIF-1α in non-small cell lung cancer cells. Zhao Y; Wang XX; Wu W; Long H; Huang J; Wang Z; Li T; Tang S; Zhu B; Chen D Biochem Biophys Res Commun; 2019 Sep; 517(2):201-209. PubMed ID: 31331645 [TBL] [Abstract][Full Text] [Related]
34. Reduction of HIF-1α/PD-L1 by Catalytic Topoisomerase Inhibitor Induces Cell Death Through Caspase Activation in Cancer Cells Under Hypoxia. Miyata S; Ishii T; Kitanaka S Anticancer Res; 2024 Jan; 44(1):49-59. PubMed ID: 38159998 [TBL] [Abstract][Full Text] [Related]
35. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery. Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380 [TBL] [Abstract][Full Text] [Related]
36. Down-regulation of TIMP2 by HIF-1α/miR-210/HIF-3α regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma. Kai AK; Chan LK; Lo RC; Lee JM; Wong CC; Wong JC; Ng IO Hepatology; 2016 Aug; 64(2):473-87. PubMed ID: 27018975 [TBL] [Abstract][Full Text] [Related]
37. Aucubin enhances the antitumor activity of cisplatin through the inhibition of PD-L1 expression in hepatocellular carcinoma. Gao ZX; Zhang ZS; Qin J; Zhang MZ; Cao JL; Li YY; Wang MQ; Hou LL; Fang D; Xie SQ Phytomedicine; 2023 Apr; 112():154715. PubMed ID: 36821999 [TBL] [Abstract][Full Text] [Related]
38. PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data. Koh YW; Lee SJ; Han JH; Haam S; Jung J; Lee HW Lung Cancer; 2019 Mar; 129():41-47. PubMed ID: 30797490 [TBL] [Abstract][Full Text] [Related]
39. Extracellular vesicles derived from lung cancer cells exposed to intermittent hypoxia upregulate programmed death ligand 1 expression in macrophages. Liu Y; Lu M; Chen J; Li S; Deng Y; Yang S; Ou Q; Li J; Gao P; Luo Z; Yuan P; Tan J; Gao X Sleep Breath; 2022 Jun; 26(2):893-906. PubMed ID: 34254261 [TBL] [Abstract][Full Text] [Related]